Abstract |
In recent years, α- tomatine has been studied for its anticancer activity. In the present study, we focused on the cytotoxic effect of α- tomatine in the MCF-7 human breast adenocarcinoma cell line, its mechanism of action, biotransformation and stability in the culture medium. We observed an inhibition of cell proliferation and viability at concentrations of 6 and 9 µM but then a recovery of cells occurred. The recovery was not caused by the biotransformation of α- tomatine in MCF-7 cells, but by a substantial decrease in the concentration of α- tomatine in the culture medium due to its binding with cholesterol. Regarding the mechanism of action of α- tomatine, we observed no DNA damage, no changes in the levels of the proteins p53 and p21(WAF1/Cip1), and no apoptosis (neither activated caspase-8 and -9, nor sub-G1 peak, or morphological signs). We found a loss of ATP in α- tomatine-treated cells. These results support the conclusion that α- tomatine does not induce apoptosis in the MCF-7 cell line.
|
Authors | Lenka Sucha, Milos Hroch, Martina Rezacova, Emil Rudolf, Radim Havelek, Ludek Sispera, Jana Cmielova, Renata Kohlerova, Ales Bezrouk, Pavel Tomsik |
Journal | Oncology reports
(Oncol Rep)
Vol. 30
Issue 6
Pg. 2593-602
(Dec 2013)
ISSN: 1791-2431 [Electronic] Greece |
PMID | 24100733
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Tumor Suppressor Protein p53
- alpha-tomatine
- Tomatine
- Cholesterol
|
Topics |
- Apoptosis
(drug effects)
- Breast Neoplasms
(drug therapy, metabolism, pathology)
- Cell Cycle
(drug effects)
- Cell Proliferation
(drug effects)
- Cell Survival
(drug effects)
- Cholesterol
(metabolism)
- Female
- Gene Expression Regulation, Neoplastic
(drug effects)
- Humans
- MCF-7 Cells
- Tomatine
(administration & dosage, analogs & derivatives)
- Tumor Suppressor Protein p53
(metabolism)
|